Similarly, IRF9, whose overexpression has been reported to cause resistance of tumor cells to drugs [37, 38] and radiation [39] and exert oncogenic effects [40, 41], has also been shown to be a key regulator for mediating the antiproliferative effect of IFN-α in tumor cells elsewhere [27, 42]. The gene discussed is IRF9; the disease is neoplasm.